Multimodality imaging review of focal renal lesions
Abstract Background Focal lesions of the kidney comprise a spectrum of entities that can be broadly classified as malignant tumors, benign tumors, and non-neoplastic lesions. Malignant tumors include renal cell carcinoma subtypes, urothelial carcinoma, lymphoma, post-transplant lymphoproliferative d...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-01-01
|
Series: | The Egyptian Journal of Radiology and Nuclear Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43055-020-00391-z |
_version_ | 1818382792671625216 |
---|---|
author | Jonathan Lyske Rishi Philip Mathew Christopher Hutchinson Vimal Patel Gavin Low |
author_facet | Jonathan Lyske Rishi Philip Mathew Christopher Hutchinson Vimal Patel Gavin Low |
author_sort | Jonathan Lyske |
collection | DOAJ |
description | Abstract Background Focal lesions of the kidney comprise a spectrum of entities that can be broadly classified as malignant tumors, benign tumors, and non-neoplastic lesions. Malignant tumors include renal cell carcinoma subtypes, urothelial carcinoma, lymphoma, post-transplant lymphoproliferative disease, metastases to the kidney, and rare malignant lesions. Benign tumors include angiomyolipoma (fat-rich and fat-poor) and oncocytoma. Non-neoplastic lesions include infective, inflammatory, and vascular entities. Anatomical variants can also mimic focal masses. Main body of the abstract A range of imaging modalities are available to facilitate characterization; ultrasound (US), contrast-enhanced ultrasound (CEUS), computed tomography (CT), magnetic resonance (MR) imaging, and positron emission tomography (PET), each with their own strengths and limitations. Renal lesions are being detected with increasing frequency due to escalating imaging volumes. Accurate diagnosis is central to guiding clinical management and determining prognosis. Certain lesions require intervention, whereas others may be managed conservatively or deemed clinically insignificant. Challenging cases often benefit from a multimodality imaging approach combining the morphology, enhancement and metabolic features. Short conclusion Knowledge of the relevant clinical details and key imaging features is crucial for accurate characterization and differentiation of renal lesions. |
first_indexed | 2024-12-14T02:56:06Z |
format | Article |
id | doaj.art-8c0e355f6e044917928c8f10a9ea76e5 |
institution | Directory Open Access Journal |
issn | 2090-4762 |
language | English |
last_indexed | 2024-12-14T02:56:06Z |
publishDate | 2021-01-01 |
publisher | SpringerOpen |
record_format | Article |
series | The Egyptian Journal of Radiology and Nuclear Medicine |
spelling | doaj.art-8c0e355f6e044917928c8f10a9ea76e52022-12-21T23:19:38ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine2090-47622021-01-0152111910.1186/s43055-020-00391-zMultimodality imaging review of focal renal lesionsJonathan Lyske0Rishi Philip Mathew1Christopher Hutchinson2Vimal Patel3Gavin Low4Department of Radiology & Diagnostic Imaging, Faculty of Medicine and Dentistry, University of AlbertaDepartment of Radiology, Rajagiri HospitalDepartment of Radiology & Diagnostic Imaging, Faculty of Medicine and Dentistry, University of AlbertaDepartment of Radiology & Diagnostic Imaging, Faculty of Medicine and Dentistry, University of AlbertaDepartment of Radiology & Diagnostic Imaging, Faculty of Medicine and Dentistry, University of AlbertaAbstract Background Focal lesions of the kidney comprise a spectrum of entities that can be broadly classified as malignant tumors, benign tumors, and non-neoplastic lesions. Malignant tumors include renal cell carcinoma subtypes, urothelial carcinoma, lymphoma, post-transplant lymphoproliferative disease, metastases to the kidney, and rare malignant lesions. Benign tumors include angiomyolipoma (fat-rich and fat-poor) and oncocytoma. Non-neoplastic lesions include infective, inflammatory, and vascular entities. Anatomical variants can also mimic focal masses. Main body of the abstract A range of imaging modalities are available to facilitate characterization; ultrasound (US), contrast-enhanced ultrasound (CEUS), computed tomography (CT), magnetic resonance (MR) imaging, and positron emission tomography (PET), each with their own strengths and limitations. Renal lesions are being detected with increasing frequency due to escalating imaging volumes. Accurate diagnosis is central to guiding clinical management and determining prognosis. Certain lesions require intervention, whereas others may be managed conservatively or deemed clinically insignificant. Challenging cases often benefit from a multimodality imaging approach combining the morphology, enhancement and metabolic features. Short conclusion Knowledge of the relevant clinical details and key imaging features is crucial for accurate characterization and differentiation of renal lesions.https://doi.org/10.1186/s43055-020-00391-zRenal cell carcinomaLymphomaPost-transplant lymphoproliferative diseaseRenal metastasesAngiomyolipomaOncocytoma |
spellingShingle | Jonathan Lyske Rishi Philip Mathew Christopher Hutchinson Vimal Patel Gavin Low Multimodality imaging review of focal renal lesions The Egyptian Journal of Radiology and Nuclear Medicine Renal cell carcinoma Lymphoma Post-transplant lymphoproliferative disease Renal metastases Angiomyolipoma Oncocytoma |
title | Multimodality imaging review of focal renal lesions |
title_full | Multimodality imaging review of focal renal lesions |
title_fullStr | Multimodality imaging review of focal renal lesions |
title_full_unstemmed | Multimodality imaging review of focal renal lesions |
title_short | Multimodality imaging review of focal renal lesions |
title_sort | multimodality imaging review of focal renal lesions |
topic | Renal cell carcinoma Lymphoma Post-transplant lymphoproliferative disease Renal metastases Angiomyolipoma Oncocytoma |
url | https://doi.org/10.1186/s43055-020-00391-z |
work_keys_str_mv | AT jonathanlyske multimodalityimagingreviewoffocalrenallesions AT rishiphilipmathew multimodalityimagingreviewoffocalrenallesions AT christopherhutchinson multimodalityimagingreviewoffocalrenallesions AT vimalpatel multimodalityimagingreviewoffocalrenallesions AT gavinlow multimodalityimagingreviewoffocalrenallesions |